Skip to content
Frenxiv is the French preprint archive for all scientific fields, operating on the Open Science Framework. About the archive
Frenxiv archive mark FrenxivFrench preprint archive

Preprint record

Mevalonate pathway, selenoproteins, redox balance, immune system, Covid 19: reasoning about connections

Giampaolo Minetti

Published May 27, 2020 DOI 10.31226/osf.io/73wy6 Publisher Frenxiv Type Preprint

Abstract

It has been proposed that a degraded immune system is (one of) the condition(s) that predispose certain subjects to fatal consequences from infection by SARS CoV 2. It is unknown whether therapeutic regimens to which these patients may have been subjected to in the months/years preceding the infection could be immunocompromising. Statins are among the most widely prescribed cholesterol lowering drugs. As competitive inhibitors of HMG CoA reductase, the key enzyme of the “mevalonate pathway” through which essential compounds, not only cholesterol, are synthesized, statins decrease the levels of cholesterol, and thus LDLs, as an innate defense mechanism, with controversial results in decreasing mortality from cardiovascular disease. Moreover, statins have pleiotropic, mostly deleterious effects on many cell types, including immune cells. In the attempt to decipher the enigma of SARS CoV 2 infectivology, the hypothesis should be tested whether the population of subjects who succumbed to Covid 19 may have developed a compromised immunity at sub clinical levels and have become more susceptible to fatal consequences from SARS Cov 2 infection due to statin therapy.

Keywords

Citation

Giampaolo Minetti (May 27, 2020). Mevalonate pathway, selenoproteins, redox balance, immune system, Covid 19: reasoning about connections. Frenxiv. https://doi.org/10.31226/osf.io/73wy6

Find this record

This record is deposited on the Open Science Framework and carries a persistent DOI. Use the links below to locate it in scholarly indexes.

Open research

Open research infrastructure

Frenxiv records connect to the wider scholarly record. These services support discovery, identifiers, preservation and open licensing.